Clinical proteomics: application at the bedside.
Petricoin
Emanuel F
EF
FDA-NCI Clinical Proteomics Program, Center for Biologic Evaluation and Research, Food and Drug Administration, NIH, Bethesda, Md., USA. petricoin@cber.fda.gov
Liotta
Lance A
LA
D015510:Clinical Medicine; D015180:Electrophoresis, Gel, Two-Dimensional / Q000379:methods; D005544:Forecasting; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis*; D009398:Nephrology / Q000592:standards / Q000639:trends; D019095:Point-of-Care Systems / Q000592:standards / Q000639:trends; D020543:Proteome / Q000032:analysis*; D040901:Proteomics / Q000592:standards / Q000639:trends*; D012680:Sensitivity and Specificity; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods
D020543:Proteome